≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

EFO MESH Endpoint Browser PheWeb

M13_CHRONSYNOVITISHANDWRIST

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M70.0, M70.1, M77.2
  • Hospital discharge: ICD-9 — 7264A
  • Cause of death: ICD-10 — M70.0, M70.1, M77.2
  • Cause of death: ICD-9 — 7264A

2 out of 7 registries used, show all original rules.

530

4. Check minimum number of events

None

530

5. Include endpoints

None

530

6. Filter based on genotype QC (FinnGen only)

530

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3653 2118 1522
Only index persons 3478 2036 1442
Unadjusted period prevalence (%)
Whole population 0.05 0.06 0.04
Only index persons 0.07 0.07 0.06
Median age at first event (years)
Whole population 51.39 52.07 50.41
Only index persons 50.83 51.70 49.59

-FinnGen-

Key figures

All Female Male
Number of individuals 530 351 179
Unadjusted period prevalence (%) 0.11 0.12 0.08
Median age at first event (years) 52.06 51.74 52.69

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
484
Matched controls
4841
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M70.0
ICD-10 Finland
Chronic crepitant synovitis of hand and wrist
2123.9
323.0
312
*
M70.1
ICD-10 Finland
Bursitis of hand
+∞
105.1
97
*
M77.2
ICD-10 Finland
Periarthritis of wrist
+∞
71.7
67
*
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
62.9
59
*
M79.6
ICD-10 Finland
Pain in limb
4.8
49.3
214
691
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
72.5
46.2
52
8
M75.1
ICD-10 Finland
Rotator cuff syndrome
5.3
40.2
141
349
M79.0
ICD-10 Finland
Rheumatism, unspecified
94.2
39.5
43
5
G56.0
ICD-10 Finland
Carpal tunnel syndrome
5.9
37.7
117
249
M65.3
ICD-10 Finland
Trigger finger
22.6
35.2
51
25
M25.5
ICD-10 Finland
Pain in joint
3.8
34.2
187
693
N02AX02
ATC
tramadol; systemic, rectal
3.3
33.0
248
1171
M19.0
ICD-10 Finland
Primary arthrosis of other joints
7.1
30.2
78
128
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
17.0
30.1
48
31
N03AX16
ATC
pregabalin; oral
3.6
27.7
150
537
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
14.3
24.7
42
32
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
131.5
23.8
25
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
8.9
23.1
50
62
M54.5
ICD-10 Finland
Low back pain
2.9
23.0
185
856
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.8
22.6
81
196
M67.4
ICD-10 Finland
Ganglion
9.0
22.0
47
57
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
21.8
251
1424
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.2
21.5
60
108
H02AB06
ATC
prednisolone; systemic
2.5
21.1
251
1441
M70.6
ICD-10 Finland
Trochanteric bursitis
4.4
20.7
81
213
M01AC06
ATC
meloxicam; systemic, rectal
2.6
20.7
211
1108
J01AA02
ATC
doxycycline; systemic
3.0
20.7
406
3070
NDL52
NOMESCO Finland
Tenosynovectomy of hand
43.8
20.6
25
6
M01AE02
ATC
naproxen; oral, rectal
2.5
20.4
296
1876
N03AX12
ATC
gabapentin; oral
3.6
19.3
95
306
N06AX21
ATC
duloxetine; oral
4.4
18.8
72
185
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
16.1
18.2
29
19
M54.4
ICD-10 Finland
Lumbago with sciatica
3.4
17.9
94
318
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
69.3
17.8
20
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
17.7
131
557
M79.7
ICD-10 Finland
Fibromyalgia
17.8
17.6
27
16
M01AH05
ATC
etoricoxib; oral
2.3
17.3
303
2032
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
17.0
189
1012
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.7
16.8
78
238
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
+∞
16.8
16
*
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
8.0
16.8
38
51
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.3
16.5
63
161
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.9
16.5
116
476
R51.80
ICD-10 Finland
Headache
3.4
16.5
89
303
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.8
16.4
56
128
M01AX17
ATC
nimesulide; oral
2.6
16.0
135
620
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
16.0
188
1027
ZXA00
NOMESCO Finland
Right side
2.5
15.7
152
750
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
14.4
15.7
26
19
M01AE03
ATC
ketoprofen; systemic, rectal
2.3
15.6
202
1154
J01DB01
ATC
cefalexin; oral
2.6
15.6
407
3235
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.3
15.4
85
296
J01DA01
ATC
[U] cefalexin; systemic
2.2
15.4
322
2285
M54.9
ICD-10 Finland
Dorsalgia, unspecified
4.0
15.2
64
179
J01FF01
ATC
clindamycin; systemic
2.5
15.1
147
728
M77.1
ICD-10 Finland
Lateral epicondylitis
4.9
15.0
50
111
S18
ICPC
Laceration/cut
2.2
14.8
208
1228
M01AX05
ATC
glucosamine; oral
2.7
14.8
111
473
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
14.8
151
763
N06AA09
ATC
amitriptyline; systemic
3.8
14.7
66
195
M13.9
ICD-10 Finland
Arthritis, unspecified
4.7
14.6
51
119
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
28.1
14.4
19
7
L08
ICPC
Shoulder symptom/complaint
2.8
14.3
99
402
A02BC02
ATC
pantoprazole; systemic
2.1
14.2
317
2271
ZXA05
NOMESCO Finland
Left side
2.4
14.0
142
710
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
13.9
64
194
M48.0
ICD-10 Finland
Spinal stenosis
3.6
13.7
65
201
M03BX02
ATC
tizanidine; oral
2.1
13.7
313
2249
R03AC02
ATC
salbutamol; inhalant
2.1
13.6
262
1750
A07EC01
ATC
sulfasalazine; oral, rectal
4.0
13.6
56
154
A02BC03
ATC
lansoprazole; oral
2.3
13.4
155
826
M02AA10
ATC
ketoprofen; topical
2.8
13.3
93
378
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.6
13.1
46
108
M01AH02
ATC
rofecoxib; oral
3.1
13.1
77
277
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
13.1
135
678
P01BA02
ATC
hydroxychloroquine; oral
3.6
13.1
60
181
N02BE01
ATC
paracetamol; systemic, rectal
2.5
12.9
417
3449
A02BC05
ATC
esomeprazole; systemic
2.1
12.6
204
1256
M01AB05
ATC
diclofenac; systemic, rectal
2.1
12.6
329
2455
M70.2
ICD-10 Finland
Olecranon bursitis
9.3
12.4
25
28
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
12.3
132
676
M79.1
ICD-10 Finland
Myalgia
3.3
12.2
63
209
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
11.9
63
213
K30
ICD-10 Finland
Functional dyspepsia
3.2
11.8
63
214
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
11.8
54
163
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
16.9
11.7
18
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
11.6
202
1270
ACC51
NOMESCO Finland
Release of median nerve
4.2
11.5
44
113
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.9
11.5
37
80
A02BC01
ATC
omeprazole; systemic
2.2
11.3
139
755
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
11.2
95
428
C03CA01
ATC
furosemide; systemic
2.2
11.0
128
676
M70.4
ICD-10 Finland
Prepatellar bursitis
16.0
10.9
17
11
J01FA06
ATC
roxithromycin; oral
2.0
10.8
198
1257
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
8.3
10.7
23
29
G44.2
ICD-10 Finland
Tension-type headache
2.7
10.6
76
312
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.4
10.6
38
92
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
10.6
89
399
M01AH01
ATC
celecoxib; oral (coxibs)
2.4
10.5
101
486
M02AA07
ATC
piroxicam; topical
2.0
10.5
179
1105
7264A
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of wrist and carpus
+∞
10.4
10
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
10.3
250
1750
N06AX16
ATC
venlafaxine; oral
2.6
10.3
77
323
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
10.3
92
424
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
10.3
53
175
UJF32
NOMESCO Finland
Coloscopy
2.2
10.3
125
672
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.8
10.2
70
279
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
5.1
10.1
31
64
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.1
10.1
39
102
N06AX11
ATC
mirtazapine; oral
2.0
10.0
153
902
S80.0
ICD-10 Finland
Contusion of knee
4.0
10.0
39
103
R42
ICD-10 Finland
Dizziness and giddiness
2.3
9.9
103
514
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
3.9
9.8
39
105
NF1AA
NOMESCO Finland
Hip X-ray examination
3.4
9.5
46
145
R60.0
ICD-10 Finland
Localized oedema
2.8
9.5
60
229
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
9.4
110
577
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
8.3
9.4
20
25
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
12.7
9.4
16
13
M09AX01
ATC
hyaluronic acid; parenteral
4.6
9.4
32
74
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
6.6
9.4
23
36
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
9.3
103
525
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
9.3
134
769
H02AB07
ATC
prednisone; oral
2.5
9.3
76
335
J01MA02
ATC
ciprofloxacin; systemic
1.9
9.2
180
1156
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
14.0
9.2
15
11
SPAT1202
SPAT
Intra-articular injection
5.3
9.2
27
53
M01AX01
ATC
nabumetone; oral
4.9
9.2
29
62
R4120
NOMESCO Finland
Occupational therapy
4.0
9.1
36
96
L12
ICPC
Hand/finger symptom/complaint
2.7
9.1
66
271
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.1
78
354
AA1AD
NOMESCO Finland
CT of head and brain
2.2
9.0
103
533
M01AE01
ATC
ibuprofen; systemic, rectal
2.3
9.0
430
3754
M77.4
ICD-10 Finland
Metatarsalgia
4.8
8.9
29
64
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.7
8.9
62
248
M70.7
ICD-10 Finland
Other bursitis of hip
7.0
8.9
21
31
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.0
8.9
139
818
L15
ICPC
Knee symptom/complaint
2.2
8.9
101
523
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
8.8
229
1612
A07AA02
ATC
nystatin; oral
3.7
8.8
38
110
M71.1
ICD-10 Finland
Other infective bursitis
50.9
8.7
10
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.5
8.6
40
123
N02AA05
ATC
oxycodone; systemic
2.5
8.6
70
309
M77.9
ICD-10 Finland
Enthesopathy, unspecified
6.2
8.5
22
37
X58
ICD-10 Finland
Exposure to other specified factors
2.5
8.5
67
290
A01
ICPC
Pain general/multiple sites
3.4
8.5
40
124
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
8.5
86
422
M54.3
ICD-10 Finland
Sciatica
3.7
8.5
36
103
H02AB04
ATC
methylprednisolone; systemic
2.3
8.4
79
374
M71.0
ICD-10 Finland
Abscess of bursa
91.6
8.4
9
*
9502
FHL
Tendon splitting (De Quervain, click finger)
91.6
8.4
9
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.9
8.4
34
93
SPAT1153
SPAT
Removal of sutures
1.9
8.4
151
936
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
8.4
137
820
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
8.4
47
164
NFM20
NOMESCO Finland
Excision of bursa of hip or thigh
+∞
8.4
8
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
8.3
57
228
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
8.3
99
524
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
8.3
55
215
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
8.2
326
2596
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
8.1
37
112
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
12.0
8.1
14
12
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
17.5
8.1
12
7
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
8.1
42
141
J45.1
ICD-10 Finland
Nonallergic asthma
3.3
8.1
39
124
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.1
7.9
42
143
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.3
7.9
20
33
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
7.9
258
1922
M01AB55
ATC
diclofenac, combinations; oral
3.2
7.9
40
132
C10AA01
ATC
simvastatin; oral
1.8
7.8
194
1330
A02BA02
ATC
ranitidine; systemic
2.1
7.8
95
503
R05
ICD-10 Finland
Cough
2.1
7.8
91
476
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
15.3
7.7
12
8
NBG10
NOMESCO Finland
Acromioplastia
15.3
7.7
12
8
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
7.6
7.7
17
23
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
7.7
40
134
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
7.7
112
638
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
7.7
80
396
M54.6
ICD-10 Finland
Pain in thoracic spine
3.3
7.6
37
118
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
18.7
7.6
11
6
L13
ICPC
Hip symptom/complaint
2.3
7.6
71
335
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.3
7.6
14
14
Z00.0
ICD-10 Finland
General medical examination
2.1
7.5
84
431
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
7.5
130
790
A02BA04
ATC
nizatidine; systemic
2.9
7.5
45
167
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
6.1
7.4
19
32
NCM20
NOMESCO Finland
Excision of synovial ganglion of elbow or forearm
81.3
7.4
8
*
SPAT1263
SPAT
Sampling
1.7
7.4
194
1349
M54.2
ICD-10 Finland
Cervicalgia
3.3
7.4
36
116
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.8
7.4
46
173
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.4
84
432
M76.0
ICD-10 Finland
Gluteal tendinitis
11.1
7.3
13
12
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
7.3
54
226
A10AA01
ATC
NA
5.3
7.3
21
41
C07AB07
ATC
bisoprolol; oral
1.7
7.3
208
1478
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
7.3
187
1289
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
7.3
76
378
L03
ICPC
Low back symptom/complaint
2.0
7.3
101
566
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.3
7.2
35
112
A01AB09
ATC
miconazole; local oral
2.6
7.2
52
212
L86
ICPC
Back syndrome with radiating pain
3.7
7.2
30
85
L17
ICPC
Foot/toe symptom/complaint
1.9
7.2
107
615
R4110
NOMESCO Finland
Physiotherapy
1.9
7.2
120
720
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
4.5
7.1
24
56
N06AX26
ATC
vortioxetine; oral
3.7
7.1
29
81
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
10.2
7.1
13
13
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.1
191
1335
R52.2
ICD-10 Finland
Other chronic pain
5.1
7.1
21
43
H04AA01
ATC
glucagon; nasal, parenteral
7.2
7.0
16
23
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.4
7.0
24
57
L40.0
ICD-10 Finland
Psoriasis vulgaris
4.0
7.0
26
67
WX110
NOMESCO Finland
Local anesthesy
1.7
7.0
311
2500
M01AH03
ATC
valdecoxib; oral
3.1
7.0
36
121
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
7.0
184
1275
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.8
7.0
44
167
R53
ICD-10 Finland
Malaise and fatigue
2.0
7.0
93
512
WX204
NOMESCO Finland
Axillary plexus blockaced
4.9
6.9
21
44
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.5
6.9
54
233
H02BX01
ATC
methylprednisolone, combinations; systemic
3.7
6.9
28
78
L16
ICPC
Ankle symptom/complaint
2.6
6.9
48
195
P03
ICPC
Feeling depressed
2.8
6.8
43
162
J01FA09
ATC
clarithromycin; systemic
1.8
6.8
148
963
L11
ICPC
Wrist symptom/complaint
2.9
6.8
39
140
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
6.8
34
112
P01
ICPC
Feeling anxious/nervous/tense
2.7
6.7
44
172
J02AC01
ATC
fluconazole; systemic
1.7
6.7
192
1359
NDL54
NOMESCO Finland
Tenolysis of hand
22.9
6.7
9
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.9
6.7
26
70
M01AC01
ATC
piroxicam; systemic, rectal
2.3
6.7
63
300
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
10.2
6.6
12
12
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.3
6.6
59
271
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
6.6
45
179
G56.2
ICD-10 Finland
Lesion of ulnar nerve
5.2
6.6
19
38
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.6
6.5
28
82
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
5.5
6.5
18
34
SPAT1229
SPAT
Assessment of need for aid
2.8
6.5
39
145
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
6.3
6.5
16
26
WX320
NOMESCO Finland
Spinalanesthesy
1.9
6.5
100
579
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.4
6.5
22
52
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
6.5
34
116
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.8
6.5
26
72
NC1BG
NOMESCO Finland
Elbow MRI examination with high intensity magnet
70.7
6.4
7
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.4
91
512
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
6.4
175
1218
C07AB02
ATC
metoprolol; systemic
2.0
6.4
89
499
B01AC04
ATC
clopidogrel; oral
2.2
6.4
63
306
M75.8
ICD-10 Finland
Other shoulder lesions
5.6
6.4
17
31
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.1
6.3
16
27
Z00.8
ICD-10 Finland
Other general examinations
2.9
6.3
37
135
NB1AD
NOMESCO Finland
Shoulder CT examination
11.2
6.3
11
10
M70.5
ICD-10 Finland
Other bursitis of knee
11.2
6.3
11
10
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
9.4
6.3
12
13
M19.8
ICD-10 Finland
Other specified arthrosis
4.4
6.3
21
49
M20.2
ICD-10 Finland
Hallux rigidus
4.4
6.3
21
49
KMAK
NOMESCO Finland
NA
1.6
6.3
235
1780
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
18.3
6.3
9
5
NCL22
NOMESCO Finland
Myotomy or tenotomy of elbow or forearm
+∞
6.3
6
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
7.2
6.3
14
20
R51.81
ICD-10 Finland
Facial pain NOS
7.2
6.3
14
20
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
6.2
44
180
J01CA04
ATC
amoxicillin; systemic
1.7
6.2
374
3210
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.0
6.2
84
464
M19.9
ICD-10 Finland
Arthrosis, unspecified
4.3
6.2
21
50
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
6.2
47
201
C10AA05
ATC
atorvastatin; oral
1.7
6.2
164
1132
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.5
6.1
27
81
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
8.8
6.1
12
14
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
6.1
24
66
N05AH04
ATC
quetiapine; oral
2.1
6.0
69
354
A06AD11
ATC
lactulose; oral
2.2
6.0
61
299
SPAT1216
SPAT
Assessment of functional ability
2.1
6.0
69
355
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
6.0
151
1023
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.5
6.0
26
77

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013826) Glucose [Moles/volume] in Serum or Plasma
343
2389
2.24
17.08
5.5
4.2
mmol/l
6.8
6.7
0.47
326
2219
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
140
682
2.43
16.64
1.4
1.2
iu/ml
28.4
35.7
0.51
51
235
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
134
648
2.43
16.14
1.4
1.2
u/ml
9.1
18.8
0.97
60
236
(3013707) Erythrocyte sedimentation rate by Westergren method
406
3069
2.38
16.05
5.9
3.7
mm/h
11.4
12.5
0.95
388
2820
(3026493) Urate [Moles/volume] in Serum or Plasma
177
1012
2.12
13.98
2.7
2.5
umol/l
324.2
8029.2
4.85
159
875
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
272
1890
1.90
11.81
4.3
3.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
287
2057
1.86
11.04
7.3
5.6
e9/l
2.0
1.9
0.09
264
1815
(3042936) Bacteria identified in Isolate by Culture
105
534
2.21
10.88
1.8
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
183
1147
1.91
10.64
2.2
2.0
u/l
152.7
278.8
0.80
173
1071
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
277
1986
1.83
10.43
8.9
6.4
mmol/l
1.2
1.2
0.10
255
1673
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
224
1513
1.83
10.19
4.7
3.2
ng/l
32.8
38.5
0.23
157
1005
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
490
4289
2.89
10.16
18.3
12.1
mg/l
19.5
23.7
2.47
420
3298
(3001604) Monocytes [#/volume] in Blood
278
2007
1.81
10.13
7.2
5.6
e9/l
0.6
0.6
0.36
248
1731
(3006315) Basophils [#/volume] in Blood
278
2016
1.80
9.90
7.3
5.6
e9/l
0.0
0.0
0.87
249
1741
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
402
3265
1.96
9.88
8.4
7.2
u/l
77.3
78.5
0.24
384
3063
(3013115) Eosinophils [#/volume] in Blood
285
2084
1.80
9.85
7.3
6.0
e9/l
0.2
0.2
0.09
262
1825
(3035350) Ketones [Presence] in Urine by Test strip
274
1983
1.79
9.78
5.3
3.4
estimate
0.0
0.0
0.00
38
354
(3026008) Bacteria identified in Urine by Culture
187
1209
1.84
9.70
3.7
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
361
2841
1.85
9.68
5.8
3.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
140
830
1.93
9.46
5.7
3.7
kg/l
1.0
1.0
2.76
24
123
(3031040) Bacteria [#/volume] in Urine by Automated count
342
2672
1.79
9.12
5.8
3.9
e6/l
101.4
3098.3
—
5
44
(3009261) Glucose [Presence] in Urine by Test strip
276
2029
1.75
9.10
5.4
3.4
estimate
0.0
0.0
0.00
41
344
(3021601) Nitrite [Presence] in Urine by Test strip
273
2006
1.74
8.97
7.2
4.7
estimate
0.0
0.0
0.00
41
356
(3013650) Neutrophils [#/volume] in Blood by Automated count
313
2392
1.75
8.93
9.3
9.3
e9/l
4.2
4.1
0.24
288
2097
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
248
1778
1.74
8.86
7.7
5.6
mmol/l
1.2
1.2
0.73
233
1607
(40761535) Cells panel - Urine sediment
65
295
2.37
8.74
5.2
3.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
231
1631
1.74
8.66
2.0
1.9
pmol/l
101.8
94.6
1.37
130
824
(3020682) Albumin/Creatinine [Ratio] in Urine
191
1285
1.76
8.44
3.8
3.9
mg/mmol
8.6
7.8
0.13
135
799
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
866
1.86
8.44
4.7
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
83
430
2.10
8.09
2.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
181
1217
1.74
7.92
3.3
3.2
mg/l
728.5
266.5
0.45
125
764
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
138
858
1.82
7.88
1.7
1.5
mg/l
1.0
1.2
0.59
112
659
(3003396) Base excess in Arterial blood by calculation
81
429
2.05
7.43
9.1
7.1
mmol/l
0.8
1.3
0.67
69
344
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
149
967
1.75
7.29
2.4
2.0
mg/l
3.0
3.1
0.08
134
819
(3019060) Gas panel - Arterial blood
51
228
2.37
7.09
4.0
4.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
184
1276
1.68
7.03
3.3
3.1
mmol/l
7.7
7.6
0.10
165
1076
(40758558) Short blood count panel - Blood
156
1040
1.71
6.88
6.1
7.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
277
2138
1.62
6.86
6.0
6.2
umol/l
10.0
11.5
2.06
270
2029
(3037522) Nuclear Ab [Titer] in Serum
92
525
1.91
6.80
1.3
1.3
titre
630.0
456.8
0.45
16
105
(3002030) Lymphocytes/100 leukocytes in Blood
257
1961
1.60
6.58
7.5
5.8
%
27.9
27.9
0.03
241
1823
(3022096) Basophils/100 leukocytes in Blood
244
1840
1.60
6.56
7.4
5.7
%
0.7
0.7
0.10
228
1706
(3019309) Folate [Moles/volume] in Red Blood Cells
114
706
1.78
6.48
1.5
1.7
nmol/l
1106.4
1177.1
0.43
99
512
(3022948) Iron [Moles/volume] in Serum or Plasma
103
619
1.82
6.47
2.5
2.3
umol/l
13.7
13.1
0.34
96
578
(3032080) INR in Blood by Coagulation assay
222
1642
1.61
6.43
8.2
8.0
inr
1.2
1.2
0.04
54
491
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
179
1259
1.64
6.35
2.9
2.3
u/l
71.1
59.8
0.39
173
1169
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
90
525
1.86
6.20
2.3
2.4
%
22.9
22.7
0.05
77
456
(3014007) Fractional oxyhemoglobin in Arterial blood
48
222
2.28
6.19
12.7
8.8
%
94.6
93.9
0.60
48
222
(3025941) Bacteria identified in Stool by Culture
45
203
2.33
6.14
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
391
3330
1.66
6.13
4.4
3.9
pmol/l
14.7
14.7
0.03
364
3020
(3018010) Neutrophils/100 leukocytes in Blood
251
1932
1.57
6.02
7.2
5.6
%
57.8
57.3
0.22
238
1805
(3006504) Eosinophils/100 leukocytes in Blood
247
1895
1.57
6.00
7.4
5.7
%
2.9
2.8
0.15
232
1759
(3044640) Blood type and Crossmatch panel - Blood
181
1292
1.61
5.98
2.3
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
451
4010
1.84
5.87
5.5
4.6
mu/l
1.8
1.9
0.81
429
3643
(3000850) Epithelial cells [#/volume] in Urine
124
811
1.69
5.76
2.5
2.4
e6/l
4.9
6.9
0.97
116
712
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
154
1067
1.62
5.71
3.5
3.0
ng/l
1645.1
1210.2
0.59
138
907
(3004789) Transferrin [Mass/volume] in Serum or Plasma
94
570
1.79
5.70
2.3
2.3
g/l
2.4
2.3
0.79
88
531
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
210
1568
1.56
5.66
5.8
3.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
231
1763
1.55
5.64
4.6
4.4
g/l
35.6
35.7
0.12
221
1646
(3023368) Bacteria identified in Blood by Culture
145
993
1.63
5.62
3.8
4.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
260
2.11
5.55
2.3
2.5
e9/l
4.0
4.0
0.08
43
204
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
224
1707
1.54
5.46
2.6
2.2
nmol/l
76.4
77.3
0.18
212
1539
(3019069) Monocytes/100 leukocytes in Blood
245
1909
1.53
5.36
7.7
5.9
%
8.6
8.7
0.05
231
1782
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
212
2.17
5.16
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1366
1.54
5.14
3.6
3.0
u/l
30.2
31.0
0.12
177
1312
(3019550) Sodium [Moles/volume] in Serum or Plasma
490
4518
2.12
5.13
20.5
13.9
mmol/l
139.6
139.7
0.41
484
4382
(3013512) EKG study
166
1199
1.56
5.08
5.2
3.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
63
349
1.91
5.07
1.8
2.1
nmol/l
398.4
375.4
0.24
54
322
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
138
956
1.60
5.04
2.2
2.1
—
—
—
0
0
(3012544) pH of Venous blood
67
380
1.87
5.02
3.0
3.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
187
1392
1.53
4.97
3.9
3.3
e6/l
147.5
81.2
0.33
155
983
(3001122) Ferritin [Mass/volume] in Serum or Plasma
232
1812
1.50
4.89
2.8
2.6
ug/l
116.1
124.3
0.27
220
1659
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
128
878
1.60
4.86
1.3
1.2
u/ml
1.5
1.7
0.07
43
228
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
114
2.54
4.79
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
490
4537
2.06
4.76
20.5
14.0
mmol/l
4.0
4.0
0.43
484
4392
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
188
1412
1.51
4.75
4.3
2.9
—
—
—
0
0
(4034850)
29
121
2.48
4.72
15.9
7.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
116
2.49
4.63
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
34
155
2.28
4.57
2.5
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
729
1.62
4.57
3.8
3.6
ng/l
149.7
517.4
1.82
83
571
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
102
671
1.64
4.56
2.6
2.4
e6/l
1.5
1.2
0.28
66
385
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
55
305
1.90
4.42
3.7
2.7
ml/min/173m2
64.4
63.4
0.07
23
125
(3030467) Casts [#/volume] in Urine by Automated count
150
1089
1.53
4.39
3.3
2.8
e6/l
0.3
0.5
0.63
128
820
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
311
2611
1.46
4.36
3.0
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
213
2.06
4.35
4.1
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
57
322
1.86
4.33
10.6
8.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
26
109
2.46
4.21
3.7
2.8
mmol/l
3.8
3.9
0.63
26
101
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
116
2.40
4.15
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
44
231
1.99
4.15
5.2
3.4
kpa
5.2
5.2
0.05
37
219
(3002032) Base excess in Venous blood by calculation
62
365
1.79
4.14
3.0
3.6
mmol/l
2.0
2.2
0.10
51
281
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
104
2.47
4.12
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
29
130
2.30
4.07
4.6
3.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
173
1313
1.47
4.04
6.9
5.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
416
3730
1.54
3.98
22.8
16.1
g/l
331.9
332.3
0.42
416
3699
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
145
2.21
3.95
1.8
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
450
4113
1.62
3.89
7.0
5.4
mmol/mol
41.6
39.4
4.37
429
3806
(3029937) Albumin [Presence] in Urine by Test strip
139
1018
1.50
3.85
6.3
3.7
estimate
0.0
0.0
0.00
39
342
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
83
2.59
3.84
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
49
3.12
3.83
1.3
1.0
u/ml
2.3
2.1
—
6
13
(3002582) Erythrocytes [#/volume] in Urine
157
1183
1.46
3.76
3.4
2.9
e6/l
28.6
117.1
0.92
138
906
(3007164) IgA [Mass/volume] in Serum or Plasma
111
781
1.53
3.70
1.4
1.5
g/l
2.3
2.4
0.16
67
482
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
184
2.03
3.68
2.1
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
42
227
1.92
3.67
5.3
3.4
ph
7.4
7.4
—
6
31
(40768797) Stomach Pathology biopsy report
85
564
1.60
3.66
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
213
1706
1.42
3.65
2.1
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
52
303
1.79
3.60
1.7
2.8
e9/l
71.8
70.3
0.13
45
228
(3048689) Calprotectin [Mass/mass] in Stool
73
468
1.65
3.60
2.2
2.2
ug/g
114.6
131.5
0.34
56
376
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
98
675
1.55
3.59
1.6
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
74
2.63
3.59
2.6
2.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
46
3.10
3.55
1.3
1.0
u/ml
2.4
6.7
—
6
11
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
260
1.84
3.52
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
216
1.92
3.51
5.3
3.3
mmol/l
1.8
2.0
0.09
28
165
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
407
1.68
3.51
1.8
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
66
415
1.67
3.51
2.7
2.5
%
1.7
1.8
0.20
60
371
(3015377) Calcium [Moles/volume] in Serum or Plasma
179
1399
1.42
3.49
2.7
3.4
mmol/l
2.3
2.4
0.27
161
1236
(3044889) 12 lead EKG panel
352
3089
1.42
3.47
4.0
3.5
—
—
—
0
0
(3019225) pH of Specimen
62
385
1.69
3.45
4.9
4.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
126
927
1.47
3.37
1.4
1.5
nmol/l
28.0
21.4
0.49
114
786
(36304419) Bacteria [Presence] in Urine
140
1055
1.44
3.30
3.2
2.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
66
2.63
3.24
1.2
1.1
u/ml
0.5
4.2
—
6
22
(3035637) Corticotropin [Mass/volume] in Plasma
12
38
3.21
3.23
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
74
490
1.59
3.21
9.3
6.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
71
466
1.60
3.20
21.7
20.4
inr
1.2
1.2
0.04
14
63
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
584
1.54
3.15
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
63
403
1.64
3.14
1.8
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
39
3.13
3.10
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
56
2.73
3.08
1.3
1.0
u/ml
0.4
4.0
—
5
10
(3022621) pH of Urine by Test strip
43
250
1.78
3.03
4.7
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
39
220
1.83
3.02
1.2
1.3
—
23.2
—
0
14
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
199
1.87
2.98
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
511
4907
2.15
2.85
26.6
18.1
e9/l
255.7
254.0
0.24
506
4761
(3021788) Differential panel - Synovial fluid
14
53
2.69
2.81
1.2
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
65
2.51
2.81
1.1
1.0
u/ml
4.4
5.4
—
6
25
(3026361) Erythrocytes [#/volume] in Blood
511
4909
2.14
2.81
26.5
18.2
e12/l
4.5
4.5
0.19
505
4755
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
494
4696
1.76
2.80
13.2
9.5
u/l
25.2
25.9
0.42
486
4512
(3010813) Leukocytes [#/volume] in Blood
511
4910
2.14
2.79
26.6
18.2
e9/l
6.9
6.6
2.96
506
4752
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
88
625
1.49
2.79
2.6
2.6
e6/l
3.2
3.1
0.01
52
342
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
51
319
1.66
2.79
2.0
1.9
—
—
—
0
0
(4010399)
47
288
1.69
2.77
1.5
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
227
1908
1.33
2.66
10.1
8.7
e9/l
0.0
0.0
0.49
190
1576
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
61
2.50
2.64
1.1
1.0
u/ml
0.2
1.2
—
5
20
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
49
2.69
2.64
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
49
2.69
2.64
1.5
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
49
2.69
2.64
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
471
0.53
2.64
1.6
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
80
2.29
2.63
2.8
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
483
4576
1.63
2.62
16.9
11.5
—
—
—
0
0
(3026782) Osmolality of Urine
104
773
1.43
2.61
3.0
2.6
mosm/kgh2o
516.8
563.1
1.71
92
659
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
50
2.64
2.55
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
50
2.64
2.55
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
122
938
1.39
2.52
6.0
4.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
45
2.71
2.46
1.4
1.3
nmol/l
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
51
2.59
2.46
1.5
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
51
2.59
2.46
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
757
1.41
2.42
2.1
3.0
mmol/l
2.4
2.5
1.28
90
675
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
320
2853
1.31
2.35
3.4
3.0
u/l
47.1
49.8
0.26
302
2671
(3000475) Leukocytes [#/volume] in Synovial fluid
17
78
2.22
2.33
1.2
1.8
e6/l
844.2
14334.2
—
9
59
(4094501)
22
113
1.99
2.28
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
86
638
1.42
2.18
1.7
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
63
442
1.48
2.14
2.3
2.5
umol/l
5.1
8.8
2.43
56
381
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
198
1.71
2.14
15.2
9.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
28
161
1.78
2.10
1.4
1.9
g/l
1.6
1.6
0.07
23
140
(3022313) Gas panel - Capillary blood
29
169
1.76
2.08
5.3
3.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
10
5.04
2.07
1.0
2.6
ug/l
1.0
1.3
—
5
10
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
7
20
3.53
2.06
1.6
1.4
mmol/l
6.2
6.9
—
7
20
(3017181) Myelocytes/100 leukocytes in Blood
51
348
1.52
1.99
4.0
4.0
%
0.2
1.1
3.00
12
99
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
14
64
2.22
1.96
1.3
1.2
mmol/l
8.6
7.4
—
9
40
(4024509)
8
27
2.99
1.94
1.9
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
106
1.92
1.93
1.3
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
10
39
2.59
1.93
4.3
4.7
mmol/l
7.2
7.3
—
10
32
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
442
4169
1.36
1.91
14.8
11.5
ml/min/173m2
79.5
80.8
0.61
381
3412
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
28
2.88
1.87
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
892
1.32
1.83
1.6
1.6
pmol/l
420.5
15107383.2
0.76
101
748
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
80
2.03
1.81
2.1
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
35
2.60
1.81
1.7
3.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
140
1.75
1.75
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
325
1.49
1.74
4.2
4.1
%
0.0
0.1
2.40
11
87
(3018418) pH of Serum or Plasma
144
1197
1.28
1.71
4.4
3.9
ph
7.4
7.4
0.32
21
221
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
293
1.51
1.71
2.6
3.1
ng/l
108.3
190.6
1.99
37
263
(3019832) Treponema pallidum Ab [Presence] in Serum
45
310
1.49
1.70
1.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
25
2.82
1.65
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
322
1.47
1.62
3.9
3.8
ng/l
84.4
82.1
0.07
41
293
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
106
1.82
1.61
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
452
4306
1.34
1.59
5.3
4.3
mmol/l
6.2
5.9
3.26
430
3931
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
114
1.78
1.58
1.7
1.4
ug/g
236.0
302.1
0.57
11
65
(3041096) Erythrocytes [Presence] in Urine by Automated
138
1153
1.27
1.57
5.5
3.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
27
2.61
1.52
2.0
1.3
%
9.6
11.4
—
7
27
(1761868) Lipid panel - Serum or Plasma
150
1749
0.80
1.50
3.3
2.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
94
1.84
1.49
1.8
2.2
u/l
3897.4
2130.1
—
6
42
(21494890) Protein electrophoresis panel - 24 hour Urine
9
37
2.46
1.48
1.0
3.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
61
458
1.38
1.48
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
355
1.42
1.46
2.3
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
81
1.88
1.41
1.4
1.2
mg/l
415.4
490.2
0.48
15
74
(3032773) Endomysium IgG Ab [Titer] in Serum
9
40
2.27
1.40
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
480
1.35
1.40
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
44
315
1.43
1.40
3.8
3.8
%
0.3
0.6
—
8
69
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
29
2.43
1.39
1.0
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
43
308
1.43
1.37
4.4
4.1
%
0.0
0.1
0.82
11
74
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
17
2.96
1.36
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
353
1.40
1.33
2.3
2.0
u/l
66.6
41.6
0.30
38
304
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
43
2.11
1.31
5.6
4.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
24
2.52
1.30
4.0
3.0
mu/l
9.3
20.1
—
6
24
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
122
1.66
1.29
1.0
1.4
miu/ml
158.2
236.5
—
5
55
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
130
1.64
1.28
1.4
1.6
iu/ml
0.1
0.1
—
7
20
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
146
1.60
1.28
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
107
1.71
1.27
1.1
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
108
1.69
1.23
1.8
3.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
27
180
1.53
1.23
2.3
4.2
mmol/l
24.4
24.1
0.10
22
164
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
537
1.31
1.21
1.5
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
71
1.85
1.20
4.0
2.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
198
1.49
1.19
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
139
1197
1.22
1.19
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
133
1.60
1.19
2.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
166
1.53
1.17
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
50
2.02
1.17
1.1
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
87
1.75
1.16
1.1
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
65
1.87
1.14
1.2
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
58
1.92
1.13
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
51
1.98
1.12
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
255
0.62
1.11
1.8
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
128
1.58
1.10
2.1
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
81
1.75
1.10
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
389
3693
1.20
1.08
19.6
15.2
%
13.7
13.7
0.20
383
3598
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
67
1.81
1.05
1.1
1.0
—
11.9
—
0
6
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
459
1.30
1.03
2.7
4.5
ug/l
2.8
38.9
1.25
49
368
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
60
1.85
1.03
2.4
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
11
60
1.85
1.03
3.2
2.7
mmol/l
108.0
105.4
1.47
11
60
(3041354) Potassium [Moles/volume] in Venous blood
11
60
1.85
1.03
3.2
2.7
mmol/l
3.9
4.0
0.38
11
60
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
60
1.85
1.03
3.2
2.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
7
34
2.07
1.03
1.1
2.9
umol/l
2.0
6.3
—
7
23
(3037121) Protein [Mass/volume] in Urine
20
131
1.55
1.01
6.1
3.4
g/l
0.2
0.2
—
10
55
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
110
0.45
1.01
1.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
206
1.43
1.01
2.8
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
107
1.61
1.01
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
267
1.37
0.99
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
29
0.00
0.98
0.0
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
13.0
—
811.5
—
0
31
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
128
1117
1.19
0.95
4.8
4.5
ug/l
2.1
2.4
0.21
116
1003
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
19.2
—
1603.1
—
0
32
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
61
493
1.27
0.94
1.9
1.8
%
1.5
1.4
0.84
55
431
(3035320) C reactive protein [Mass/volume] in Body fluid
6
27
2.24
0.93
1.7
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
55
1.83
0.92
2.1
2.0
%
13.2
13.2
—
10
55
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
464
4502
1.25
0.91
5.7
4.7
mmol/l
2.7
2.8
1.59
446
4154
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
439
4237
1.21
0.90
4.6
3.9
mmol/l
1.4
1.3
1.60
415
3891
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
135
1.50
0.90
1.3
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
19
127
1.51
0.89
7.1
4.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
57
1.77
0.84
1.0
1.1
—
—
—
0
0
(44790047)
8
46
1.75
0.83
1.3
1.8
—
—
—
0
0
(44806118)
8
46
1.75
0.83
1.3
1.8
—
—
—
0
0
(44790049)
8
46
1.75
0.83
1.3
1.8
—
—
—
0
0
(44790048)
8
46
1.75
0.83
1.3
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
422
1.26
0.79
1.6
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
115
1.49
0.77
1.8
2.1
g/l
4.0
3.6
0.37
17
110
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
34
262
1.32
0.77
5.4
2.9
u/ml
22.0
46.4
1.57
34
252
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
75
1.61
0.75
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
75
1.61
0.75
1.1
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
454
4414
1.20
0.75
5.2
4.3
mmol/l
4.7
4.8
0.54
436
4102
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
54
1.68
0.75
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
25
2.01
0.73
2.6
3.3
u/ml
440.0
924.2
—
5
25
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
60
1.68
0.72
1.4
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
40
1.76
0.71
6.6
3.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
57
1.59
0.71
1.0
1.0
g/l
1.3
1.5
—
9
50
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
57
1.59
0.71
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
61
1.65
0.69
1.8
2.7
%
65.1
63.4
—
10
61
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
42
1.68
0.68
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
13
191
0.67
0.68
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
39
313
1.27
0.67
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
94
0.53
0.67
1.2
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
86
1.52
0.66
1.4
1.8
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
44
1.60
0.65
2.1
1.7
mmol/l
1.3
1.5
—
7
44
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
17
120
1.43
0.65
1.9
1.6
g/l
0.2
0.3
0.28
17
113
(3045788) Cell count panel - Pleural fluid
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
79
1.53
0.63
1.2
2.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
1654.9
—
0
20
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
53
1.52
0.58
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
123
1.39
0.58
1.9
1.6
g/l
1.2
1.2
0.31
17
116
(3005570) Glucose [Moles/volume] in Urine
6
35
1.72
0.58
1.2
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
36
1.67
0.57
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
479
1.19
0.55
1.7
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
151
1.34
0.54
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
66
1.53
0.53
1.5
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
75
1.48
0.51
2.0
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
65
1.39
0.51
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
67
1.50
0.50
1.1
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
128
1.34
0.48
3.2
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
288
0.79
0.48
1.3
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
146
1.31
0.47
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
448
4388
1.14
0.47
5.0
4.3
mmol/l
1.5
1.5
0.75
425
4047
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
120
1.34
0.46
2.0
2.4
u/ml
0.2
0.3
—
8
68
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
526
1.16
0.46
5.0
4.4
%
33.4
32.5
0.27
48
346
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
69
1.46
0.44
1.5
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
51
1.38
0.44
1.3
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
104
1.36
0.43
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
15
113
1.34
0.43
1.1
1.2
—
6.1
—
0
9
(3023199) Leukocytes [#/volume] in Pleural fluid
5
31
1.62
0.43
1.0
1.2
e6/l
1587.6
1770.6
—
5
19
(3000093) Morphology [Interpretation] in Blood Narrative
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
56
1.44
0.42
1.5
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
99
904
1.12
0.42
4.8
4.1
%
21.6
21.0
0.19
55
431
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
149
1.29
0.42
2.3
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.0
mg/l
266.4
286.8
—
5
26
(40768441) Liver Pathology biopsy report
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
1.5
—
108054.7
—
0
10
(3024932) HLA-DR beta [Type]
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(4281824)
8
60
1.34
0.40
1.3
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
115.2
—
0
13
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
0.3
—
0
12
(40760888) Immunoglobulin light chains.free panel - Serum
13
97
1.35
0.40
1.1
3.9
—
—
—
0
0
(3000492) Spirometry study
44
382
1.17
0.39
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
366
1.16
0.37
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
81
1.37
0.36
2.5
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
181
1.22
0.35
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
145
1.25
0.34
1.4
1.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
145
1.25
0.34
1.4
1.6
g/l
7.2
7.5
0.35
11
110
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
145
1.25
0.34
1.4
1.6
g/l
3.8
3.9
0.07
11
106
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
91
1.33
0.34
1.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
285
0.83
0.33
1.6
1.4
—
—
—
0
0
(3010421) pH of Blood
6
86
0.69
0.33
3.5
3.3
ph
7.4
7.4
—
6
66
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
74
1.36
0.32
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
47
1.28
0.32
1.8
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
110
1.28
0.32
1.7
2.0
iu/l
4.3
6.5
—
5
39
(3023511) Choriogonadotropin [Units/volume] in Urine
7
54
1.30
0.30
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
55
1.28
0.30
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.28
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
72
1.25
0.25
1.7
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
123
1.23
0.25
1.2
1.0
—
5.7
—
0
20
(3004588) Protein electrophoresis panel - Serum or Plasma
30
264
1.14
0.25
1.3
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
124
1177
1.07
0.25
1.8
1.6
mmol/l
1.4
1.4
0.11
109
987
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
106
1.23
0.23
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
134
1.20
0.23
2.3
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.2
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
7
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
43
1.16
0.21
1.6
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
43
1.16
0.21
2.8
2.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
14
0.00
0.20
0.0
1.1
—
369.6
—
0
8
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.1
—
14.6
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
49
1.23
0.20
1.8
3.8
u/ml
12.1
40.5
—
6
49
(3050129) First trimester maternal screen panel - Serum or Plasma
12
99
1.22
0.19
1.6
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
60
1.17
0.18
1.0
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.4
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
60
1.17
0.18
6.0
3.1
e9/l
2.7
4.0
—
7
60
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
63
1.11
0.17
6.4
3.3
%
49.1
58.0
—
7
63
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
68
0.73
0.17
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
173
0.86
0.17
1.4
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
68
1.18
0.16
5.9
3.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
68
1.18
0.16
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
80
0.75
0.15
1.8
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
83
1.09
0.14
4.8
3.8
u/ml
17.6
3374.5
—
9
78
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
415
0.93
0.12
3.4
3.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
408
4044
1.04
0.12
18.4
13.6
%
38.7
39.8
1.19
294
2929
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
423
0.94
0.10
2.0
1.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
44
1.14
0.10
1.6
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
340
0.94
0.09
6.4
3.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
48
1.04
0.09
2.0
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
72
0.83
0.07
1.5
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
74
0.81
0.07
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
84
1.07
0.07
1.3
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
55
569
0.96
0.07
1.4
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
92
0.87
0.07
1.3
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
77
751
1.03
0.06
1.4
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
121
0.91
0.06
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
29
303
0.95
0.05
1.2
1.2
iu/ml
227.8
155.7
0.41
13
123
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
64
655
0.97
0.04
3.5
2.9
ug/l
0.7
0.7
0.24
46
431
(4035726)
41
401
1.02
0.02
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
113
1.06
0.02
1.3
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
113
1.06
0.02
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
114
1.05
0.00
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
114
1.05
0.00
1.3
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
107
1.03
0.00
1.4
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
113
0.97
0.00
2.7
2.8
mg/l
1.8
1.6
0.29
11
102
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
133
0.98
0.00
1.2
1.6
—
80.0
—
0
5
(3021387) Prolactin [Units/volume] in Serum or Plasma
12
118
1.02
0.00
1.8
1.4
mu/l
227.8
313.9
0.96
12
107
(3049717) Cytology report of Urine Cyto stain
14
138
1.01
0.00
2.9
2.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
36.0
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
55
0.91
0.00
2.6
2.8
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
4949.2
—
0
5
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.5
—
0.2
—
0
6
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
69
0.87
0.00
1.5
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
79
0.88
0.00
1.6
1.7
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
5
57
0.88
0.00
1.6
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
16.0
—
0
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
93
0.97
0.00
1.9
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
69
0.87
0.00
1.5
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.3
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_CHRONSYNOVITISHANDWRIST and mortality.

Females

Parameter HR [95% CI] p-value
M13_CHRONSYNOVITISHANDWRIST 1.108 [0.94, 1.3] 0.21
Birth year 0.995 [0.99, 1.0] 0.231

During the follow-up period (1.1.1998 — 31.12.2019), 269 out of 1878 females with M13_CHRONSYNOVITISHANDWRIST died.

Males

Parameter HR [95% CI] p-value
M13_CHRONSYNOVITISHANDWRIST 1.158 [0.99, 1.36] 0.074
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 238 out of 1368 males with M13_CHRONSYNOVITISHANDWRIST died.

Mortality risk

Mortality risk for people of age

years, who have M13_CHRONSYNOVITISHANDWRIST.

N-year risk Females Males
1 0.098% 0.258%
5 0.652% 1.328%
10 1.581% 3.134%
15 2.973% 5.697%
20 5.195% 10.039%

Relationships between endpoints

↥

Index endpoint: M13_CHRONSYNOVITISHANDWRIST – Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data